RxDoctor Payments Data

Navinder Sethi, MD

Orthopaedic Surgery of the Spine · Bethesda, MDNPI 1306840244

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $104,363 of the $114,394 with a category attached, or 91.2%. Alphatec Spine, Inc accounts for 86.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $35,208 and has fallen 91.6% since, to $2,962 in 2025.

$114,394in general payments, 2019–2025

Across 128 payments — averaging $893.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$99K
  • Ortho Development Corporation$5K
  • Boston Scientific$5K
  • Spine Wave, Inc.$3K
  • Supreme Orthopedic Systems, LLC$768
  • Arthrex$563
  • plus $809 from 10 others

What the payments were for

  • Royalty or licence$104,36391%
  • Consulting fees$4,5254%
  • Speaking & faculty fees$1,9252%
  • Travel & lodging$1,8482%
  • Food & beverage$1,7332%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$114,394 in reported general payments places this provider in the 80th percentile of 49 orthopaedic surgery of the spine providers in Maryland.

See all orthopaedic surgery of the spine providers in Maryland

Medicare billing

Part B allowed, 2024
$394,168
Medicare patients
633
Services billed
2,782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium190$1,263
Methylprednisolone158$1,072
Cyclobenzaprine Hcl68$462
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen54$357
Meloxicam79$302
Oxycodone Hcl34$229
Tramadol Hcl67$177
Gabapentin18$128
Diazepam11$16

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →